Incidental Mutation 'IGL01396:Slc25a21'
ID79446
Institutional Source Australian Phenomics Network (link to record)
Gene Symbol Slc25a21
Ensembl Gene ENSMUSG00000035472
Gene Namesolute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21
Synonyms9930033G19Rik
Accession Numbers
Is this an essential gene? Possibly non essential (E-score: 0.319) question?
Stock #IGL01396
Quality Score
Status
Chromosome12
Chromosomal Location56712634-57197472 bp(-) (GRCm38)
Type of Mutationmissense
DNA Base Change (assembly) A to G at 57159189 bp
ZygosityHeterozygous
Amino Acid Change Valine to Alanine at position 19 (V19A)
Ref Sequence ENSEMBL: ENSMUSP00000151751 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000044634] [ENSMUST00000110680] [ENSMUST00000217690]
Predicted Effect probably benign
Transcript: ENSMUST00000044634
SMART Domains Protein: ENSMUSP00000039289
Gene: ENSMUSG00000035472

DomainStartEndE-ValueType
Pfam:Mito_carr 10 104 2.3e-24 PFAM
Pfam:Mito_carr 107 200 1.3e-16 PFAM
Pfam:Mito_carr 202 298 3.4e-20 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000110680
AA Change: V19A

PolyPhen 2 Score 0.000 (Sensitivity: 1.00; Specificity: 0.00)
SMART Domains Protein: ENSMUSP00000106308
Gene: ENSMUSG00000035472
AA Change: V19A

DomainStartEndE-ValueType
Pfam:Mito_carr 28 111 4.7e-21 PFAM
Pfam:Mito_carr 114 207 7.7e-17 PFAM
Pfam:Mito_carr 209 305 2e-20 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000217690
AA Change: V19A

PolyPhen 2 Score 0.000 (Sensitivity: 1.00; Specificity: 0.00)
Coding Region Coverage
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] SLC25A21 is a homolog of the S. cerevisiae ODC proteins, mitochondrial carriers that transport C5-C7 oxodicarboxylates across inner mitochondrial membranes. One of the species transported by ODC is 2-oxoadipate, a common intermediate in the catabolism of lysine, tryptophan, and hydroxylysine in mammals. Within mitochondria, 2-oxoadipate is converted into acetyl-CoA.[supplied by OMIM, Apr 2004]
Allele List at MGI
Other mutations in this stock
Total: 54 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
2310003L06Rik T A 5: 87,972,790 Y469N probably benign Het
Actl11 T C 9: 107,928,765 S96P possibly damaging Het
Ankrd13b T A 11: 77,472,372 probably null Het
Apobec4 T A 1: 152,756,266 I15K probably damaging Het
Arhgef28 G T 13: 97,953,893 D1039E probably damaging Het
Atp1a1 C T 3: 101,591,453 G175R probably damaging Het
AU040320 T A 4: 126,869,378 probably benign Het
Bcl9l G A 9: 44,506,824 R653H probably damaging Het
Ccdc141 T A 2: 77,128,325 I144L possibly damaging Het
Cdh20 C T 1: 104,947,429 T312I possibly damaging Het
Cdh23 C T 10: 60,385,069 V1297I possibly damaging Het
Cfap57 T C 4: 118,610,595 Y315C probably damaging Het
Chd8 A G 14: 52,204,587 probably benign Het
Cog5 A G 12: 31,894,096 D660G probably benign Het
Cps1 T C 1: 67,157,786 I332T probably damaging Het
Csgalnact2 T C 6: 118,126,327 T225A probably damaging Het
Dchs1 A G 7: 105,772,283 L310P probably damaging Het
Dgki T C 6: 37,000,090 N695S probably damaging Het
Gas7 T A 11: 67,652,914 probably null Het
Gm21286 T C 4: 60,838,324 noncoding transcript Het
Gm4799 C T 10: 82,954,684 noncoding transcript Het
Hdac4 T C 1: 91,959,474 probably benign Het
Hif1a T A 12: 73,940,533 S467T probably benign Het
Ier5 A G 1: 155,098,550 V294A probably damaging Het
Ifna11 T C 4: 88,820,077 V40A probably benign Het
Itga9 T C 9: 118,607,123 probably benign Het
Lbx1 G T 19: 45,234,231 Q118K probably benign Het
Lta A T 17: 35,204,085 probably null Het
Matr3 A G 18: 35,588,389 Y471C probably damaging Het
Nrg2 A T 18: 36,045,852 probably benign Het
Olfr1156 G T 2: 87,949,863 F123L probably damaging Het
Olfr1195 C T 2: 88,683,231 C167Y probably damaging Het
Olfr1301 T A 2: 111,754,603 M118K probably damaging Het
Olfr1301 T C 2: 111,754,503 F85L probably benign Het
Patl1 A G 19: 11,923,883 K299R probably damaging Het
Pdgfrb A G 18: 61,072,664 E574G probably damaging Het
Phf3 G A 1: 30,804,305 Q1858* probably null Het
Prkca T C 11: 108,014,322 K197E possibly damaging Het
Psmc6 C A 14: 45,343,667 Q307K probably benign Het
Rasa1 T C 13: 85,258,442 I181V probably benign Het
Scel A G 14: 103,608,094 probably benign Het
Scn5a A T 9: 119,534,704 S457T probably damaging Het
Sesn3 A G 9: 14,321,078 T216A probably benign Het
Slc34a1 A G 13: 55,402,733 T81A probably damaging Het
Slc35a5 A G 16: 45,151,503 Y117H probably damaging Het
Sptbn4 A G 7: 27,414,771 V569A probably benign Het
Sqle A G 15: 59,323,874 Y333C probably damaging Het
Svep1 T C 4: 58,068,552 E3078G possibly damaging Het
Tacc2 T A 7: 130,759,189 I2737N probably damaging Het
Tet3 A T 6: 83,369,638 Y1272* probably null Het
Tnr G T 1: 159,897,024 R1095L possibly damaging Het
Vmn1r184 T C 7: 26,267,437 S203P probably damaging Het
Vmn2r94 A G 17: 18,257,039 L370P probably damaging Het
Xrcc5 A G 1: 72,354,245 H559R probably benign Het
Other mutations in Slc25a21
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00471:Slc25a21 APN 12 56718137 splice site probably null
IGL00776:Slc25a21 APN 12 56770205 missense probably benign 0.43
IGL00788:Slc25a21 APN 12 56713812 utr 3 prime probably benign
IGL01656:Slc25a21 APN 12 56738495 missense probably damaging 1.00
IGL03095:Slc25a21 APN 12 56738625 missense probably benign 0.09
R0285:Slc25a21 UTSW 12 56858025 critical splice donor site probably null
R1238:Slc25a21 UTSW 12 56738487 missense probably benign 0.00
R1509:Slc25a21 UTSW 12 56858079 missense probably benign 0.00
R1803:Slc25a21 UTSW 12 56858087 missense probably benign 0.01
R3862:Slc25a21 UTSW 12 56718135 splice site probably benign
R4684:Slc25a21 UTSW 12 57196936 missense probably benign 0.00
R4816:Slc25a21 UTSW 12 56713838 missense probably damaging 1.00
R5718:Slc25a21 UTSW 12 56718156 missense probably benign 0.00
R6265:Slc25a21 UTSW 12 57196900 missense probably benign 0.33
R6953:Slc25a21 UTSW 12 57159169 missense probably benign
R7337:Slc25a21 UTSW 12 56858043 missense probably benign 0.03
U24488:Slc25a21 UTSW 12 56738497 missense possibly damaging 0.66
Posted On2013-11-05